Delivery Order SPE2DB22D3301-SPE2DB25FZ1CC
- Not listed
- The Defense Logistics Agency awarded a $33,528.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gamunex-C 10 gram/100 mL vials. The contract is scheduled for completion by October 17, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials with a ceiling value of $1,214.68. This is a firm fixed-price delivery order without set-aside designation, with an ultimate completion date of September 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials valued at $3,644.04 with a completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,926.40 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract, with no set-aside designation, is scheduled for completion by October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials with a completion date of September 23, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $3,036.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials. The contract is set to be completed by September 10, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive global...
- The Defense Logistics Agency awarded a $2,360.28 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Gamunex-C 20 gram/200 milliliter vials, with a completion date of May 15, 2025. This competitively awarded, firm fixed-price order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 10 gram/100 mL vials valued at $18,314.10 with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1CCDelivery Order
The Defense Logistics Agency awarded a $14,651.28 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 10 gram/100 mL vials (100 mL quantity). This is a firm fixed-price, non-set-aside contract with a completion date of October 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical supply framework, the company maintains an extensive portfolio delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers globally. This specific delivery order for Gamunex-C, an immunoglobulin therapy product, exemplifies the company's ongoing role in supplying specialty pharmaceuticals to support military medical readiness and personnel healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 9/17/25 |